Sarepta Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +347.6% | -45.7% | +26.5% | +172.0% | -3.6% | -15.4% | +64.8% | -39.5% | +97.8% | -27.6% | -5.4% | -33.9% | +135.1% | -23.4% | +18.3% | +277.0% | +42.2% | +1.2% | -7.2% | +54.9% | +208.4% | +25.5% | +11.0% | +63.7% | +5.5% | -0.6% | +4.4% | +21.4% | -15.5% | |
| – | +490.0% | -49.2% | +30.0% | +183.2% | -17.0% | -25.8% | +88.2% | -47.4% | +140.9% | -30.2% | -15.4% | -40.6% | +201.0% | -26.3% | +19.4% | +329.2% | +39.7% | -8.5% | -9.4% | +66.3% | +229.0% | +16.1% | +3.0% | +69.2% | +4.8% | -1.8% | +0.8% | +19.2% | -17.4% | |
| – | +486.7% | -51.7% | +2.4% | +197.7% | -57.3% | -6.2% | +20.6% | +33.0% | +107.7% | -41.7% | +23.0% | -54.9% | +331.3% | -30.4% | +18.8% | +370.3% | +36.9% | -71.4% | +9.2% | +52.4% | +389.9% | -38.2% | +125.2% | +79.9% | +40.8% | -54.3% | -55.7% | +157.5% | -27.4% | |
| – | +486.7% | -51.7% | +36.5% | +176.8% | -20.3% | -24.6% | +94.9% | -48.1% | +141.1% | -29.5% | -24.4% | -54.2% | +322.2% | -30.7% | +18.8% | +370.3% | +36.9% | -18.1% | -8.5% | +65.1% | +239.5% | +8.8% | -4.2% | +72.4% | +9.1% | -6.0% | -15.7% | -19.2% | -30.6% | |
| – | – | – | – | – | – | -70.1% | – | – | – | -95.8% | +5,472.6% | +73.2% | -58.1% | +54.6% | +12.7% | +29.7% | -25.1% | -31.6% | +64.6% | +31.5% | +463.7% | +66.4% | +91.5% | +47.5% | +23.9% | +52.4% | +67.0% | +48.7% | -20.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +724,999,900.0% | +361.6% | -19.7% | -52.3% | +552.5% | +50.0% | +36.6% | +35.3% | -19.7% | +9.5% | +58.3% | +132.3% | +22.0% | |
| – | – | – | – | – | +372.3% | +34.4% | +6.4% | -9.9% | -11.3% | -22.7% | +57.6% | -24.0% | -52.5% | -16.1% | +106.0% | -20.4% | +343.0% | +155.8% | -3.0% | +1.2% | +14.2% | +124.8% | +33.6% | +46.9% | +0.4% | +28.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +16.7% | +14.3% | +11.3% | +54.6% | +15.3% | +8.1% | +14.7% | +7.6% | +20.8% | +19.9% | +6.6% | +15.0% | +5.9% | +19.7% | +3.1% | +2.6% | +16.8% | +12.7% | +21.6% | +77.7% | -19.4% | +8.0% | +9.1% | +4.5% | -46.8% | +290.9% | -9.2% | +7.7% | |
| – | -85.3% | +140.0% | -16.7% | +72.3% | +90.5% | +56.1% | -26.8% | -40.0% | +22.2% | +14.7% | +289.0% | -20.0% | +271.2% | +34.1% | -52.1% | +248.2% | -45.4% | +6.8% | +76.1% | +4.8% | +493.4% | +17.6% | +64.7% | +121.3% | -0.1% | +23.6% | -12.3% | +1.3% | -9.3% | |
| – | +66.7% | +140.0% | -16.7% | +72.3% | +90.5% | +56.1% | -26.8% | -40.0% | +22.2% | +14.7% | +209.5% | -25.3% | +359.8% | +36.9% | -55.1% | +282.9% | -54.4% | +2.5% | +69.0% | +21.1% | +17.1% | +96.6% | +52.4% | +57.1% | +8.8% | +36.9% | +5.5% | +11.9% | +49.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | +3.7% | +4.4% | +5.2% | +4.9% | +4.7% | -10,731.5% | – | +225.4% | +19.9% | -38.9% | +2,071.6% | -94.1% | +2,366.9% | +40.4% | -94.3% | +696.2% | -89.1% | -15.4% | |
| – | +0.0% | +350.0% | -22.2% | +84.4% | +114.8% | +63.8% | -32.8% | -52.3% | +27.8% | -24.7% | +115.9% | -33.4% | -31.4% | -5.1% | +616.7% | -19.8% | +134.1% | -29.6% | +63.1% | +46.7% | -71.5% | +299.5% | +101.3% | +63.1% | -30.9% | +24.9% | +72.0% | +30.0% | +31.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -3.4% | -3.8% | -4.3% | -4.6% | -5.1% | -5.5% | +137.2% | +300.5% | -59.6% | +6,932.0% | -1.0% | +62.1% | +45.5% | +10.5% | +40.8% | -26.7% | +0.4% | -27.1% | |
| – | +2,187.5% | -50.8% | +32.2% | +180.4% | -8.5% | -23.1% | +84.8% | -39.5% | +104.3% | -29.7% | -30.0% | -40.4% | +50.2% | -111.9% | – | +298.7% | +99.9% | +0.2% | -23.1% | +76.9% | +134.4% | +30.8% | -20.7% | -6.9% | +21.8% | -58.5% | +123.2% | +77.8% | -25.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +20.0% | +17.1% | +13.9% | +39.3% | +19.6% | +14.7% | +16.0% | +20.8% | +24.1% | +17.9% | +2.4% | +28.8% | +34.0% | +19.5% | +16.5% | +9.3% | +43.4% | +18.2% | +5.7% | +15.2% | +20.8% | +12.6% | +11.1% | +5.9% | +4.2% | +7.7% | +5.5% | +16.8% | -2.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.